The Committee on Clinical Pharmacology and Pharmacogenomics at the University of Chicago, chaired by Peter H. O'Donnell, MD, is seeking motivated trainees for our clinical pharmacology and pharmacogenomics fellowship training program.
The NIH NIGMS funded program is open to those interested in personalized medicine, pharmacogenomics, new drug development, clinical pharmacology, clinical trial design, genetics of drug abuse and/or clinical trial design.
Our two-year American Board of Clinical Pharmacology (ABCP) accredited program is a multidisciplinary, comprehensive and collaborative initiative that emphasizes individual creativity in the context of an encouraging environment. Trainees will have the opportunity to tailor their work to emphasize clinical, translational or basic science research spending protected time devoted their research efforts with the remainder dedicated to core curriculum, clinical activities and required rotations (as applicable). After successful completion, trainees are eligible to become board certified in Clinical Pharmacology.
Those eligible with an MD, MD/PhD, PharmD, PharmD/PhD, or PhD can find general information at: http://ccpp.uchicago.edu/ or contact the program administrator, Kendall Kartaly at Kendall.Kartaly@bsd.uchicago.edu
The University of Chicago is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, protected veteran status or status as an individual with disability.
